Gadoxetate Disodium

Tier C — Watch / trade

Gadoxetate Disodium

Bayer

Originator

2004

First approval

Expiry (public)

No sales data

Peak sales

In vivo diagnostic

Type

Targets：Not applicable

Brand：Primovist, Eovist

Indications (approved)：Contrast imaging, Diagnostic agent

Regional status

Approved

2008-07-03

Approved

2004-03-26

China

Approved

2010-09-25

Japan

Approved

2007-10-19

Factories producing this API2

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

2 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Gadoxetate Disodium?

Approved indications include: Contrast imaging, Diagnostic agent.

When does the Gadoxetate Disodium patent expire?

No public expiry year is available for Gadoxetate Disodium yet; this page updates once verified.

How do I get a quote for Gadoxetate Disodium intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27